Akèy › Kontwòl Pwa
Etid klinik pou Kontwòl Pwa ap rekrite nan Etazini
84 etid pou Kontwòl Pwa ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY11 etid
- Aurora, CO7 etid
- Washington, DC5 etid
- Baltimore, MD5 etid
- Chicago, IL5 etid
- Kansas City, KS4 etid
- Dallas, TX4 etid
- Edison, NJ4 etid
- Durham, NC4 etid
- Los Angeles, CA4 etid
- Nashville, TN3 etid
- Houston, TX3 etid
- Birmingham, AL3 etid
- Kansas City, MO3 etid
- Rochester, MN3 etid
- San Diego, CA3 etid
- Providence, RI3 etid
- Cleveland, OH3 etid
- Charleston, SC3 etid
- San Antonio, TX3 etid
- Columbus, OH3 etid
Pa eta
- Alabama3 etid
- Colorado8 etid
- Distrik Columbia4 etid
- Florid7 etid
- Georgia4 etid
- Illinois6 etid
- Kalifòni10 etid
- Kansas6 etid
- Maryland6 etid
- Michigan3 etid
- Minnesota4 etid
- Missouri4 etid
- New Jersey4 etid
- New York11 etid
- North Carolina7 etid
- Ohio6 etid
- Rhode Island3 etid
- South Carolina4 etid
- Tennessee3 etid
- Texas11 etid
- Virginia3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou Sep 29, 2026 · NCT07846033FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06724406Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07399678A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou Sep 24, 2026 · NCT07838740Visugromab in Cachexia International Trial
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07112196Georgia CEAL RESTORES Family Diabetes Study
Ap rekriteVolontè an sante akeyi
Laj 12 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07808723Plant-Based Online Weight Loss Through Education and Resources Program and Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07095543Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07015424HealthyTogether: RCT of a Dyadic Weight Management Intervention
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT06619041Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
Ap rekrite
Laj 18 a 35 · Tout sèks · Mizajou Aug 11, 2026 · NCT06961591Phentermine's Impact on Treatment in Teens
Ap rekriteFaz 2
Laj 12 a 17 · Tout sèks · Mizajou Aug 10, 2026 · NCT07282340Atomoxetine in Melanocortin Obesity Syndrome
Ap rekriteFaz 2
Laj 6 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06899178Planning Grant for TOPS for Breast Cancer Survivors
Ap rekrite
Laj 21 a 90 · Fanm · Mizajou Aug 5, 2026 · NCT06658912Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
Ap rekrite
Laj 18 a 50 · Tout sèks · Mizajou Jul 31, 2026 · NCT06325722Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07702461Effects of GLP-1 RAs on Human Lactation Outcomes
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Fanm · Mizajou Jul 22, 2026 · NCT07720414Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
Ap rekriteEtid obsèvasyon
Laj 12 a 17 · Tout sèks · Mizajou Jul 21, 2026 · NCT06967389Small Extracellular Vesicles and Insulin Action
Ap rekriteVolontè an sante akeyi
Laj 25 a 55 · Tout sèks · Mizajou Jul 17, 2026 · NCT05933707Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT05705492Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06937177Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT06138821Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT07227051Reversal of Lipid-Induced Insulin Resistance
Ap rekriteVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Jun 22, 2026 · NCT02193295Body Composition Outcomes in MS Patients
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT07530718Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.